Aptose Biosciences Inc
TSX:APS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aptose Biosciences Inc
TSX:APS
|
CA |
|
R
|
Resonac Holdings Corp
XMUN:SWD
|
JP |
|
N
|
NVR Inc
F:NVE
|
US |
|
Veeco Instruments Inc
NASDAQ:VECO
|
US |
|
P
|
Procter & Gamble Co
BMV:PG
|
US |
|
Japan Hotel Reit Investment Corp
TSE:8985
|
JP |
|
Ikegps Group Ltd
NZX:IKE
|
NZ |
|
Softronic AB
STO:SOF B
|
SE |
|
Carmila SA
PAR:CARM
|
FR |
|
B
|
Braxia Scientific Corp
CNSX:BRAX
|
CA |
|
Okta Inc
NASDAQ:OKTA
|
US |
|
Walmart Inc
NASDAQ:WMT
|
US |
|
Marathon Petroleum Corp
NYSE:MPC
|
US |
|
Elior Group SA
PAR:ELIOR
|
FR |
|
Vail Resorts Inc
NYSE:MTN
|
US |
|
A
|
Astro Malaysia Holdings Bhd
KLSE:ASTRO
|
MY |
|
Celyad Oncology SA
F:1C0
|
BE |
|
Planet Fitness Inc
NYSE:PLNT
|
US |
|
A
|
Auckland International Airport Ltd
ASX:AIA
|
NZ |
|
Gujarat State Fertilizers and Chemicals Ltd
NSE:GSFC
|
IN |
|
Plazza AG
SIX:PLAN
|
CH |
|
Waste Management Inc
NYSE:WM
|
US |
|
Warner Music Group Corp
NASDAQ:WMG
|
US |
|
S
|
Sinergi Inti Andalan Prima Tbk PT
IDX:INET
|
ID |
Bankruptcy Probability
Aptose Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptose Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
5.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
379.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptose Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptose Biosciences Inc has total debt of 10m USD. This includes both short-term (0 USD) and long-term (10m USD) debt.
You can find a full breakdown on its Balance Sheet.
